发明名称 ENHANCEMENT OF TRANSGENE EXPRESSION FROM VIRUS-BASED VACCINE VECTORS USING SUPPRESSORS OF THE TYPE 1 INTERFERON RESPONSE
摘要 Baculovirus vectors with improved ability to express transgenes are provided. The baculovirus vectors are genetically engineered to contain and express nucleic acid sequences that encode one or more proteins that interfere with mammalian host cell type I interferon (IFN) responses. Thus, the expression of transgenes encoded by the baculovirus vector is not inhibited by a type I DFN response, and the transgenes are freely expressed in mammalian host cells. Alternatively, baculovirus vectors with nucleotide sequences encoding one or more genes of interest (e.g. tuberculosis or malarial antigens) are co-administered with one or more proteins that interfere with mammalian host cell type I IFN responses; or with viral vectors (e.g. adenovectors) that express one or more proteins that interfere with mammalian host cell type I IFN responses.
申请公布号 WO2010025016(A2) 申请公布日期 2010.03.04
申请号 WO2009US52969 申请日期 2009.08.06
申请人 AERAS GLOBAL TB VACCINE FOUNDATION;SADOFF, JERALD, C.;FULKERSON, JOHN;STONE, MICHELE 发明人 SADOFF, JERALD, C.;FULKERSON, JOHN;STONE, MICHELE
分类号 C12N15/866;A61K38/21;C12N15/20 主分类号 C12N15/866
代理机构 代理人
主权项
地址